BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9811516)

  • 1. Development of working reagents and international standards.
    Saldanha J
    Biologicals; 1998 Jun; 26(2):115-7. PubMed ID: 9811516
    [No Abstract]   [Full Text] [Related]  

  • 2. International standardization of gene amplification technology.
    Robertson JS
    Biologicals; 1998 Jun; 26(2):111-3. PubMed ID: 9811515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. World Health Organization collaborative study to establish a replacement WHO international standard for hepatitis C virus RNA nucleic acid amplification technology assays.
    Saldanha J; Heath A; Aberham C; Albrecht J; Gentili G; Gessner M; Pisani G
    Vox Sang; 2005 Apr; 88(3):202-4. PubMed ID: 15787732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardization: a progress report.
    Saldanha J
    Biologicals; 1999 Dec; 27(4):285-9. PubMed ID: 10686054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verification and validation of diagnostic laboratory tests in clinical virology.
    Rabenau HF; Kessler HH; Kortenbusch M; Steinhorst A; Raggam RB; Berger A
    J Clin Virol; 2007 Oct; 40(2):93-8. PubMed ID: 17766174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of an 'in-house' PCR assay validated for the detection of hepatitis C virus RNA.
    Lombardi GR; Oviedo A; Freytes F; Zarzur J; Guglielmone H; Vitali MS
    Transfus Med; 2008 Oct; 18(5):317-9. PubMed ID: 18937742
    [No Abstract]   [Full Text] [Related]  

  • 7. Elimination of false-negative hepatitis C virus RNA results by removal of inhibitors in cadaver-organ donor blood specimens.
    Padley DJ; Lucas SB; Saldanha J
    Transplantation; 2003 Jul; 76(2):432-4. PubMed ID: 12883207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Planning and significance of tests to confrim the presence of anti-hepatitis-C antibodies in blood donors. Spanish Study Group for Blood Donors at Risk].
    León P; Echevarría JM
    Sangre (Barc); 1999 Oct; 44(5):309-14. PubMed ID: 10618905
    [No Abstract]   [Full Text] [Related]  

  • 9. [Role of molecular biology investigations in the detection of Hepatitis C virus].
    Miseta A
    Orv Hetil; 2002 Jun; 143(24):1507. PubMed ID: 12138649
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary data for genotype distribution and epidemiological aspects of hepatitis C virus infection in blood donors from Yucatan, Mexico.
    García-Montalvo BM; Macossay-Castillo M
    Transfus Med; 2007 Dec; 17(6):488-90. PubMed ID: 18067653
    [No Abstract]   [Full Text] [Related]  

  • 12. Large scale PCR screening of pooled plasma samples for HIV-1 and HCV.
    Smith R; Heldebrant C
    Dev Biol (Basel); 2000; 102():109-11. PubMed ID: 10794097
    [No Abstract]   [Full Text] [Related]  

  • 13. [The prospect on the technique of test for blood donor infected with hepatitis C virus during the infectious window period].
    Zheng H
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):159-60. PubMed ID: 11983147
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening of blood donations by hepatitis C virus polymerase chain reaction (HCV-PCR) improves safety of blood products by window period reduction.
    Hitzler WE; Runkel S
    Clin Lab; 2001; 47(5-6):219-22. PubMed ID: 11405599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of validation studies from a fractionator's point of view.
    Zerlauth G
    Biologicals; 1999 Dec; 27(4):295-301. PubMed ID: 10686056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence analysis confirmation of transfusion-transmitted hepatitis C by red blood cells that tested negative by minipool hepatitis C virus nucleic acid testing.
    Grabarczyk P; Gronowska A; Brojer E; Letowska M; Radziwon P
    Transfusion; 2007 Jun; 47(6):1102-4. PubMed ID: 17524106
    [No Abstract]   [Full Text] [Related]  

  • 17. HCV RNA detection in heparinized blood by direct genomic RNA capture onto paramagnetic particles.
    van Doorn LJ; Shyamala V; Han JH; Kleter GE
    J Virol Methods; 1994 Jul; 48(2-3):339-41. PubMed ID: 7989448
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevention of transfusion-associated viral infection].
    Kojima K; Togashi T
    Rinsho Byori; 2003 Feb; Suppl 124():121-6. PubMed ID: 12710042
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthetic viral particles promise to be valuable in the standardization of molecular diagnostic assays for hepatitis C virus.
    Cartwright CP
    Clin Chem; 1999 Dec; 45(12):2057-9. PubMed ID: 10585336
    [No Abstract]   [Full Text] [Related]  

  • 20. Reliable detection and quantitation of viral nucleic acids in oral fluid: Liquid phase-based sample collection in conjunction with automated and standardized molecular assays.
    Raggam RB; Wagner J; Michelin BD; Putz-Bankuti C; Lackner A; Bozic M; Stauber RE; Santner BI; Marth E; Kessler HH
    J Med Virol; 2008 Sep; 80(9):1684-8. PubMed ID: 18649328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.